Agile Therapeutics, Inc

Agile Therapeutics, Inc. is a pharmaceutical product development company founded in 1997 based on developing novel pharmaceutical products utilizing its proprietary transdermal drug delivery technology. The company's lead product is a second generation contraceptive patch, currently in phase II clinical testing. Agile's technology is making the trusted oral contraceptive hormones, levonorgestrel and ethinyl estradiol, available for the first time in a small, visually appealing 7-day patch. The market demand for transdermal contraception is strong, and this new product will add an attractive choice for women who wish to utilize this method of contraception but prefer a small patch with the same hormone combination found in popular oral contraceptives. The company is backed by a solid management team and committed investors.

Contact Details: One Tower Bridge, 100 Front Street West Conshohocken Pennsylvania 19428 United States of America Tel: 610 940 0300 Fax: 610 940 .0301 Email: daria@whiteseahorse.com WWW: www.AGILETHERAPEUTICS.COM/

Loading...

Press Releases on Agile Therapeutics, Inc:
Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch	16th October, 2009	Frost & Sullivan	MOUNTAIN VIEW, Calif., Oct. 16 /PRNewswire/ -- Based on its annual assessment of companies making innovative contributions in healthcare, Frost & Sullivan recognizes Agile Therapeutics, Inc.
Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch	3rd September, 2008	Agile Therapeutics, Inc.	PRINCETON, N.J., Sept. 3 /PRNewswire/ -- Agile Therapeutics, Inc., announced today that it successfully completed two key clinical trials in the development of the company's new, innovative

BioNews Results for Agile Therapeutics, Inc:
Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch	KOTA Territory News:  Oct 19 2009 3:49AM Matching: agile therapeutics inc
Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch	Montana's News Station:  Oct 16 2009 9:34PM Matching: agile therapeutics inc
Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch	Pharmacy Choice:  Oct 16 2009 9:31PM Matching: agile therapeutics inc
Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch	Therapeutics Daily:  Oct 16 2009 12:23PM Matching: agile therapeutics inc
Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch	Individual.com:  Oct 16 2009 12:24PM Matching: agile therapeutics inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Agile Therapeutics, Inc news.

Agile Therapeutics, Inc Patents:
US Patent No.	Title
7384650	Skin permeation enhancement composition for transdermal hormone delivery system
7045145	Transdermal contraceptive delivery system and process

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 384 times since April 2007, the link to the organisation's website has been followed 50 times

Search for more companies in West Conshohocken

Search for more companies in Pennsylvania

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Agile Therapeutics, Inc